These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23548499)

  • 1. Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3.
    Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW
    Nephron Clin Pract; 2012; 122(1-2):58-65. PubMed ID: 23548499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
    Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
    J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between chronic kidney disease and cardiovascular disease risk factors in atomic bomb survivors.
    Sera N; Hida A; Imaizumi M; Nakashima E; Akahoshi M
    Radiat Res; 2013 Jan; 179(1):46-52. PubMed ID: 23148507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study.
    Baek SD; Baek CH; Kim JS; Kim SM; Kim JH; Kim SB
    Scand J Urol Nephrol; 2012 Jun; 46(3):232-8. PubMed ID: 22545920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of clustering of major cardiovascular risk factors with chronic kidney disease in the adult population.
    Kong X; Ma X; Cui M; Xu D
    Clin Nephrol; 2014 Aug; 82(2):92-7. PubMed ID: 24887299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the World Kidney Day campaign on the awareness of chronic kidney disease and the status of risk factors for cardiovascular disease and renal progression.
    Chin HJ; Ahn JM; Na KY; Chae DW; Lee TW; Heo NJ; Kim S
    Nephrol Dial Transplant; 2010 Feb; 25(2):413-9. PubMed ID: 19783595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years.
    Rashidi A; Sehgal AR; Rahman M; O'Connor AS
    Am J Cardiol; 2008 Dec; 102(12):1668-73. PubMed ID: 19064021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of renal damage with cardiovascular diseases is independent of individual cardiovascular risk profile in hypertension: data from the Italy - Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study.
    Sciarretta S; Valenti V; Tocci G; Pontremoli R; Rosei EA; Ambrosioni E; Costa V; Leonetti G; Pessina AC; Trimarco B; Chin D; Paneni F; Deferrari G; Ferrucci A; Volpe M
    J Hypertens; 2010 Feb; 28(2):251-8. PubMed ID: 19812502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Egypt Information, Prevention, and Treatment of Chronic Kidney Disease (EGIPT-CKD) programme: prevalence and risk factors for microalbuminuria among the relatives of patients with CKD in Egypt.
    Gouda Z; Mashaal G; Bello AK; El Attar A; El Kemmry T; El Reweny A; El Nahas M
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1055-63. PubMed ID: 21912051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of risk factors for cardiovascular disease and the rate of glomerular filtration: a cross-sectional study in the population from certain areas of Beijing].
    Wang F; Ye P; Xiao WK; Luo LM; Wu HM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Mar; 31(3):256-9. PubMed ID: 20510047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification of cardiovascular events in patients at all stages of chronic kidney disease using myocardial perfusion SPECT.
    Yoda S; Nakanishi K; Tano A; Kasamaki Y; Kunimoto S; Matsumoto N; Sato Y; Hirayama A
    J Cardiol; 2012 Nov; 60(5):377-82. PubMed ID: 22890072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk prediction.
    Chang A; Kramer H
    Nephron Clin Pract; 2011; 119(2):c171-7; discussion c177-8. PubMed ID: 21811078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of chronic kidney disease in Jing adults in China: a village-based study.
    Xue C; Ye XD; Li W; Peng Q; Ding HY; Zhang YH; He DF; Bai X; Huang Y; Song YS; Pang L; Liao YH
    Clin Nephrol; 2013 Jan; 79(1):50-6. PubMed ID: 22948117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of socioeconomic factors on cardiovascular disease risk factors in the context of economic development in the Samoan archipelago.
    Ezeamama AE; Viali S; Tuitele J; McGarvey ST
    Soc Sci Med; 2006 Nov; 63(10):2533-45. PubMed ID: 16876925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of cardiovascular risk in Chinese chronic kidney disease patients].
    Hou FF; Ma ZG; Mei CL; Rong S; Huang SM; Liu XR; Yuan WJ; Guo YS; Wang L; He Q; Wang XL; Sang XH; Li XL
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):753-9. PubMed ID: 15949381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of regional deprivation and individual socio-economic status on the prevalence of Type 2 diabetes in Germany. A pooled analysis of five population-based studies.
    Maier W; Holle R; Hunger M; Peters A; Meisinger C; Greiser KH; Kluttig A; Völzke H; Schipf S; Moebus S; Bokhof B; Berger K; Mueller G; Rathmann W; Tamayo T; Mielck A;
    Diabet Med; 2013 Mar; 30(3):e78-86. PubMed ID: 23127142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age- and sex-tailored serum phosphate thresholds do not improve cardiovascular risk estimation in CKD.
    Ferraro PM; Bonello M; Gambaro A; Sturniolo A; Gambaro G
    J Nephrol; 2011; 24(4):446-52. PubMed ID: 21607913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study.
    Nakayama M; Sato T; Miyazaki M; Matsushima M; Sato H; Taguma Y; Ito S
    Hypertens Res; 2011 Oct; 34(10):1106-10. PubMed ID: 21796127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.